Indications
Open Access TIMES Journals
Login
Register
Login
Register
Indications
Oncology · Hematology
Cardiovascular
Diabetes + Endocrinology
Pneumology
Ophthalmology
Gynecology · Urology
Dermatology · Immunology · Rheumatology
Neurology · Psychiatry
Gastroenterology
Infectiology · Anesthesiology · Pain
Primary Care
Open Access TIMES Journals
Oncology · Hematology
Cardiovascular
Diabetes + Endocrinology
Pneumology
Ophthalmology
Gynecology · Urology
Dermatology · Immunology · Rheumatology
Neurology · Psychiatry
Gastroenterology
Infectiology · Anesthesiology · Pain
Primary Care
Gynecology · Urology
Case Reports
Expert Opinions
Webinar
Faculty
Homepage
>
Gynecology · Urology
>
Articles
Treatment by rituximab on six Grave's ophthalmopathies resistant to corticosteroids
Share:
Related content
Uveitis
Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial
JAMA.
Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Keenan JD, Rao MM, Ebert CD, Nguyen HH, Kim E, Porco TC, Acharya NR, FAST Research Group.
doi: 10.1001/jama.2019.12618.
Macular Diseases
Retinal Diseases
A meta-analysis of patients with treatment-resistant macular oedema secondary to retinal vein occlusions following switching to aflibercept
Acta Ophthalmol.
Spooner K Hong T, Bahrami B, Chang A
doi: 10.1111/aos.13802.
Uveitis
Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials
Ophthalmology.
Suhler EB, Thorne JE, Mittal M, Betts KA, Tari S, Camez A, Bao Y, Joshi A
doi: 10.1016/j.ophtha.2017.06.017.
Macular Diseases
Development and testing of a patient-derived questionnaire for treatment of neovascular age-related macular degeneration: dimensions of importance in treatment of neovascular age-related macular degeneration
Acta Ophthalmol.
Jelin E, Wisløff T, Moe MC, Heiberg T
doi: 10.1111/aos.13847.
Macular Diseases
RANIBIZUMAB TREATMENT IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Results From LUMINOUS, a Global Real-World Study
Retina.
Holz FG, Figueroa MS, Bandello F, Yang Y, Ohji M, Dai H, Wykrota H, Sharma S, Dunger-Baldauf C, Lacey S, Macfadden W, Mitchell P
doi: 10.1097/IAE.0000000000002670.
Macular Diseases
Characteristics of Eyes With Good Visual Acuity at 5 Years After Initiation of Treatment for Age-Related Macular Degeneration but Not Receiving Treatment From Years 3 to 5: Post Hoc Analysis of the CATT Randomized Clinical Trial
JAMA Ophthalmol.
Scoles D, Ying GS, Pan W, Hua P, Grunwald JE, Daniel E, Jaffe GJ, Toth CA, Martin DF, Maguire MG, Comparison of AMD Treatments Trials Research Group.
doi: 10.1001/jamaophthalmol.2019.5831.
Cornea and Corneal Diseases
Moraxella Keratitis: Analysis of Risk Factors, Clinical Characteristics, Management, and Treatment Outcomes
Am J Ophthalmol.
Durrani AF, Faith SC, Kowalski RP, Yu M, Romanowski E, Shanks R, Dhaliwal D1, Jhanji V
doi: 10.1016/j.ajo.2018.
Non-surgical treatment for eyelid retraction in thyroid eye disease (TED)
Br J Ophthalmol.
Grisolia ABD, Couso RC, Matayoshi S, Douglas RS, Briceño CA
doi: 10.1136/
Uveitis
Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis
Cochrane Database Syst Rev.
Barry RJ, Tallouzi MO, Bucknall N, Mathers JM, Murray PI, Calvert MJ, Moore DJ, Denniston AK
doi: 10.1002/14651858.